Evidence map›Paper›PMID 38600158›Full record

ArticleScientific reports2024

Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia.

Hamenth Kumar Palani, Saravanan Ganesan, Nithya Balasundaram, Arvind Venkatraman, Anu Korula, Aby Abraham, Biju George, Vikram Mathews

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Leukemic Stem Cells and Hematological Malignancies.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hamenth Kumar Palani *Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Saravanan Ganesan *Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Nithya BalasundaramDepartment of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Arvind VenkatramanDepartment of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Anu KorulaDepartment of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Aby AbrahamDepartment of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Biju GeorgeDepartment of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Vikram MathewsDepartment of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India. vikram@cmcvellore.ac.in.
Christian Medical College & Hospital · IN

Funding

DBT-Wellcome Trust India Alliance IA/TSG/23/1/600452Wellcome Trust
6 · The paper itself

Abstract

The survival of leukemic cells is significantly influenced by the bone marrow microenvironment, where stromal cells play a crucial role. While there has been substantial progress in understanding the mechanisms and pathways involved in this crosstalk, limited data exist regarding the impact of leukemic cells on bone marrow stromal cells and their potential role in drug resistance. In this study, we identify that leukemic cells prime bone marrow stromal cells towards osteoblast lineage and promote drug resistance. This biased differentiation of stroma is accompanied by dysregulation of the canonical Wnt signaling pathway. Inhibition of Wnt signaling in stroma reversed the drug resistance in leukemic cells, which was further validated in leukemic mice models. This study evaluates the critical role of leukemic cells in establishing a drug-resistant niche by influencing the bone marrow stromal cells. Additionally, it highlights the potential of targeting Wnt signaling in the stroma by repurposing an anthelmintic drug to overcome the microenvironment-mediated drug resistance.

Indexed as

Leukemia, Myeloid, AcuteMesenchymal Stem CellsAnimalsBone MarrowBone Marrow CellsDrug ResistanceMiceStromal CellsTumor MicroenvironmentWnt Signaling Pathway

Identifiers

PMID38600158
PMCPMC11006665
OpenAlexW4394692250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.